Viewing Study NCT03081494

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:31 AM
Ignite Modification Date: 2026-02-11 @ 12:38 PM
Study NCT ID: NCT03081494
Status: COMPLETED
Last Update Posted: 2020-12-11
First Post: 2017-03-10
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase Ib Study of PDR001 in Combination With Regorafenib in Adult Patients With Previously Treated Metastatic Colorectal Cancer
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Colorectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None PDR001 View
None MCC View
None immunotherapy View
None regorafenib View
None CRC View
None MMS View
None CMS4 View
None ElevatION:CRC-102 View